Skip to main content

Table 2 Clinicopathological variables of GC patients

From: NEAT1 can be a diagnostic biomarker in the breast cancer and gastric cancer patients by targeting XIST, hsa-miR-612, and MTRNR2L8: integrated RNA targetome interaction and experimental expression analysis

Characteristic Status Number of patients (%)
Blood Group A +  9 (18%)
B +  7 (14%)
B- 11 (22%)
O +  5 (10%)
O- 3 (6%)
AB 12 (24%)
Unknown 4 (8%)
Smoking Yes 14 (28%)
No 36 (72%)
Unknown 0
H. Pylori Positive 12 (24%)
Negative 21 (42%)
Unknown 17 (34%)
Tumor Stage I 12 (24%)
II 11 (22%)
III 8 (16%)
IV 13 (26%)
Unknown 6 (12%)
Metastasis Positive 19 (38%)
Negative 21 (42%)
Unknown 10 (20%)
Tumor Size  > 6 cm 17 (34%)
 < 6 cm 31 (62%)
Unknown 2 (4%)
Tumor location Greater curvature 17 (34%)
Lesser curvature 12 (24%)
Cardia 10 (20%)
Antrum 11 (22%)
Unknown 0
Histological type Mucinous adenocarcinoma 11 (22%)
Intestinal 12 (24%)
Signet ring cell 16 (32%)
Unknown 6 (12%)